Better Therapeutics, Inc. Common Stock (BTTX)

BTTX was delisted on the 15th of March, 2024.

• Market cap: $2.43M
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.

Employees: 54